+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Harvard Bioscience Inc (HBIO) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 48 Pages
  • September 2024
  • GlobalData
  • ID: 4400038
Harvard Bioscience Inc (HBIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Harvard Bioscience Inc (Harvard Bioscience) develops, manufactures and markets instruments, consumables, systems, and software. The company’s products include spectrophotometers, plate readers, gel electrophoresis equipment, amino acid analyzers, electroporation and electrofusion instruments, wireless monitors, data acquisition and analysis products and software, and syringe pump and peristaltic pumps, among others. It also provides data analysis, training, and installation services. Harvard Bioscience serves research scientists at pharmaceutical and biotechnology companies, hospitals, universities, government laboratories, and contract research organizations. It markets products directly in the US, the UK, Germany, France, Sweden, Canada, Italy, Spain and China; and also through a network of distributors in other countries. Harvard Bioscience is headquartered in Holliston, Massachusetts, the US.

Harvard Bioscience Inc Key Recent Developments

  • May 07, 2024: Harvard Bioscience Announces First Quarter 2024 Financial Results
  • Apr 09, 2024: Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
  • Mar 07, 2024: Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
  • Feb 27, 2024: Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call For March 7, 2024 at 8:00 Am ET

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Harvard Bioscience Inc - Key Facts
  • Harvard Bioscience Inc - Key Employees
  • Harvard Bioscience Inc - Key Employee Biographies
  • Harvard Bioscience Inc - Major Products and Services
  • Harvard Bioscience Inc - History
  • Harvard Bioscience Inc - Company Statement
  • Harvard Bioscience Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Harvard Bioscience Inc - Business Description
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: Greater China
  • Performance
  • Geographical Segment: Rest of the World
  • Performance
  • Geographical Segment: United States
  • Performance
  • R&D Overview
  • Harvard Bioscience Inc - Corporate Strategy
  • Harvard Bioscience Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Harvard Bioscience Inc - Strengths
  • Harvard Bioscience Inc - Weaknesses
  • Harvard Bioscience Inc - Opportunities
  • Harvard Bioscience Inc - Threats
  • Harvard Bioscience Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Recent Developments
  • May 07, 2024: Harvard Bioscience Announces First Quarter 2024 Financial Results
  • Apr 09, 2024: Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
  • Mar 07, 2024: Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
  • Feb 27, 2024: Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call For March 7, 2024 at 8:00 Am ET
  • Nov 06, 2023: Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023
  • Sep 18, 2023: Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research
  • Jun 20, 2023: Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
  • Apr 25, 2023: Harvard Bioscience Announces First Quarter 2023 Financial Results
  • Apr 18, 2023: Harvard Bioscience Announces Initial Order for Integrated Animal Behavior Monitoring System
  • Mar 09, 2023: Harvard Bioscience Announces Fourth Quarter 2022 Financial Results
Section 5 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Harvard Bioscience Inc, Key Facts
  • Harvard Bioscience Inc, Key Employees
  • Harvard Bioscience Inc, Key Employee Biographies
  • Harvard Bioscience Inc, Major Products and Services
  • Harvard Bioscience Inc, History
  • Harvard Bioscience Inc, Subsidiaries
  • Harvard Bioscience Inc, Key Competitors
  • Harvard Bioscience Inc, Ratios based on current share price
  • Harvard Bioscience Inc, Annual Ratios
  • Harvard Bioscience Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Harvard Bioscience Inc, Performance Chart (2019 - 2023)
  • Harvard Bioscience Inc, Ratio Charts

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Razel Scientific Instruments Inc
  • Revvity Inc
  • Danaher Corp
  • Thermo Fisher Scientific Inc
  • Lonza Group Ltd
  • Eppendorf SE
  • Kent Scientific Corporation
  • Becton Dickinson and Co
  • Bio-Rad Laboratories Inc
  • Fulcrum Biometrics LLC